glutathione parkinson's disease clinical trial Multi-omics study identifies diagnostic metabolic
Multi omics study identifies diagnostic metabolic signatures of early Parkinson's disease associated with dysregulated glutathione and TCA cycle metabolism ScienceDirect Glutathione & Parkinson's: Evidence, Biomarkers, Safety PlexusDx Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update Kevin McFarthing, Susan Buff, Gary Rafaloff, Brian Fiske, Leah Mursaleen, Rosie Fuest, Richard K. Wyse, Simon R.W. Stott, 2023 Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Pay in 4 interest-free payments of $6.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



